Abstract
Mouse B16 melanoma cells rapidly develop resistance to the antiproliferative effects of interferon α (IFNα) and interferon β (IFNβ) when they are exposed to the interferons in vitro. This resistance was characterized to be non-genetic and dose-dependent, and does not alter other IFN-induced effects such as antiviral effects and elevation of 2′,5′-oligoadenylate synthetase activity in IFN-treated cells. The study of these IFN-resistant cells has been extended to an in vivo tumor model. Resistance, if it occurred in vivo, did not adversely affect the survival of IFN-treated mice. Further, IFN-treated mice inoculated with B16 cells that were resistant in vitro (B16αres cells) survived significantly longer than IFN-treated mice inoculated with B16 cells that were sensitive in vitro. The IFN-treated B16αres-inoculated mice had a significantly higher cure rate as well. The prolonged survival of the mice bearing B16αres cell tumors did not seem to be caused by the slower growth rate of the B16αres cells, since experiments performed with a tenfold higher B16αres cell inoculum and a tenfold lower B16 cell inoculum did not show any change in the survival pattern. It is clear that in vitro resistant B16αres cells are more sensitive to antitumor effects induced by IFN in vivo than in vitro sensitive B16 cells.
Key words: Melanoma, Antitumor response, Interferon resistance, rHuIFNαA/D
Footnotes
Supported by U. S. Public Health Service grant no. CA50752 awarded by the National Cancer Institute, Department of Health and Human Services (W. R. F.) and by a James W. McLaughlin Fellowship (C. M. F.)
References
- 1.Belardelli F, Gresser I, Maury C, Maunoury M-T. Antitumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend leukemia cells. I. Int J Cancer. 1982;30:813. doi: 10.1002/ijc.2910300621. [DOI] [PubMed] [Google Scholar]
- 2.Belardelli F, Gresser I, Maury C, Mounoury M-T. Antitumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend leukemia cells. II. Role of host mechanisms. Int J Cancer. 1982;30:821. doi: 10.1002/ijc.2910300622. [DOI] [PubMed] [Google Scholar]
- 3.Brunda M, Rosenbaum D, Stern L. Inhibition of experimentally-induced murine metastases by recombinant alpha interferon: correlation between the modulatory effect of interferon treatment on natural killer cell activity and inhibition of metastases. Int J Cancer. 1984;34:421. doi: 10.1002/ijc.2910340321. [DOI] [PubMed] [Google Scholar]
- 4.Brunda M, Sulich V, Bellantoni D. The anti-tumor effect of recombinant interferon alpha or gamma is influenced by tumor location. Int J Cancer. 1987;40:807. doi: 10.1002/ijc.2910400617. [DOI] [PubMed] [Google Scholar]
- 5.Campbell JB, Grunberger T, Kochman MA, White SL. A microplaque reduction assay for human and mouse interferon. Can J Microbiol. 1975;21:1247. doi: 10.1139/m75-186. [DOI] [PubMed] [Google Scholar]
- 6.Faltynek CR, Princler GL, Schwabe M, Shata MT, Lewis GK, Kamin-Lewis RM. Characterization of the binding of radioiodinated hybrid recombinant IFNαA/D to murine and human lymphoid cell lines. J Interferon Res. 1990;10:55. doi: 10.1089/jir.1990.10.55. [DOI] [PubMed] [Google Scholar]
- 7.Fidler IJ. Selection of successive tumor lines for metastasis. Nat New Biol. 1973;242:148. doi: 10.1038/newbio242148a0. [DOI] [PubMed] [Google Scholar]
- 7.Fleischmann CM, Fleischmann WR., Jr Resistance to the antiproliferative activity of IFNα: further characterization and demonstration of antagonistic effects of IFNγ. J Biol Regul Homeost Agents. 1991;5:34. [PubMed] [Google Scholar]
- 9.Fleischmann WR., Jr Potentiation of the direct anticellular activity of mouse interferons: mutual synergism and interferon concentration dependence. Cancer Res. 1982;42:869. [PubMed] [Google Scholar]
- 10.Fleischmann WR, Jr, Fleischmann CM, Gindhart T. Effect of hyperthermia on the antiproliferative activities of murine α, β, and γ-interferons: differential enhancement of murine γ-interferon. Cancer Res. 1986;46:8. [PubMed] [Google Scholar]
- 11.Fleischmann CM, Fleischmann WR., Jr Differential antiproliferative activities of IFNs α, β, and γ: kinetics of establishment of their antiproliferative effects and the rapid development of resistance to IFNs α and β. J Biol Regul Homeost Agents. 1988;2:173. [PubMed] [Google Scholar]
- 12.Fleischmann WR, Jr, Fleischmann CM, et al. Mechanisms of interferons' antitumor actions. In: Baron S, Coppenhaver D, Dianzani F, et al., editors. Interferon: principles and medical applications. Galveston: The University of Texas Medical Branch; 1992. p. 299. [Google Scholar]
- 13.Fleischmann WR, Jr, Koren S, Fleischmann CM. Orally administered interferons exert their white blood cell suppressive effects via a novel mechanism. Proc Soc Exp Biol Med. 1992;201:200. doi: 10.3181/00379727-201-43499. [DOI] [PubMed] [Google Scholar]
- 14.Gresser I. Antitumor effects of interferons: past, present and future. Br J Haematol. 1991;79(Suppl 1):1. doi: 10.1111/j.1365-2141.1991.tb08108.x. [DOI] [PubMed] [Google Scholar]
- 15.Gresser I, Maury C, Carnaud C, De Mayer E, Maunoury M-T, Belardelli F. Antitumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend erythroleukemia cells. VIII. Role of the immune system in the inhibition of visceral metastases. Int J Cancer. 1990;46:468. doi: 10.1002/ijc.2910460324. [DOI] [PubMed] [Google Scholar]
- 16.Lee S, Chiu H, Rinderknecht E, Sabo W, Stebbing N. Importance of treatment regimen of interferon as an antitumor agent. Cancer Res. 1983;43:4172. [PubMed] [Google Scholar]
- 17.Maekawa R, Kitagawa T, Hojo K, Wada T, Sato K. Distinct antitumor mechanisms of recombinant murine interferon-γ against two murine tumor models. J Interferon Res. 1988;8:227. doi: 10.1089/jir.1988.8.227. [DOI] [PubMed] [Google Scholar]
- 18.Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55. doi: 10.1016/0022-1759(83)90303-4. [DOI] [PubMed] [Google Scholar]
- 19.Nishimura J, Mitsui K, Ishikawa T, et al. Antitumor and antimetastatic activities of human recombinant interferon alpha A/D. Clin Exp Metastasis. 1985;3:295. doi: 10.1007/BF01585083. [DOI] [PubMed] [Google Scholar]
- 20.Ramani P, Balkwill F. Action of recombinant alpha interferon against experimental and spontaneous metastases in a murine model. Int J Cancer. 1989;43:140. doi: 10.1002/ijc.2910430126. [DOI] [PubMed] [Google Scholar]
- 21.Rehberg E, Kelder B, Hoal EG, Pestka S. Specific molecular activities of recombinant and hybrid leukocyte interferons. J Biol Chem. 1982;257:11497. [PubMed] [Google Scholar]
- 22.Reid TR, Race ER, Wolff BH, Friedman RM, Merigan TC, Basham TY. Enhanced in vivo therapeutic response to interferon in mice with an in vitro interferon-resistant B-cell lymphoma. Cancer Res. 1989;49:4163. [PubMed] [Google Scholar]
- 23.Tabata Y, Uno K, Muramatsu S, Ikada Y. In vivo effects of recombinant interferon alpha A/D incorporated in gelatin microspheres on murine tumor cell growth. Jpn J Cancer Res. 1989;80:387. doi: 10.1111/j.1349-7006.1989.tb02324.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Tada H, Shiho O, Kurushima K, Koyama M, Tsukamoto K. An improved colorimetric assay for interleukin 2. J Immunol Methods. 1986;93:157. doi: 10.1016/0022-1759(86)90183-3. [DOI] [PubMed] [Google Scholar]
- 25.Uno K, Shimizu S, Ido M, et al. Direct and indirect effects of interferon on in vivo murine tumor cell growth. Cancer Res. 1985;45:1320. [PubMed] [Google Scholar]
- 26.Uno K, Shimizu S, Inaba K, et al. Effect of recombinant human interferon-αA/D on in vivo murine tumor cell growth. Cancer Res. 1988;48:2366. [PubMed] [Google Scholar]